VRS
NBIX icon

Virginia Retirement Systems’s Neurocrine Biosciences NBIX Stock Holding History

Virginia Retirement Systems’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.4M Buy
245,923
+70,900
+41% +$10.5M 0.25% 115
2026
Q1 		$23.1M Buy
175,023
+27,400
+19% +$3.64M 0.17% 152
2025
Q4 		$20.9M Buy
147,623
+49,200
+50% +$7.13M 0.12% 177
2025
Q3 		$13.8M Buy
98,423
+13,300
+16% +$1.8M 0.09% 213
2025
Q2 		$10.7M Sell
85,123
-334,500
-80% -$38.4M 0.07% 224
2025
Q1 		$46.4M Buy
+419,623
New +$53.2M 0.34% 81
2023
Q3 		$67.6M Buy
600,823
+456,800
+317% +$48.1M 0.67% 31
2023
Q2 		$13.6M Sell
144,023
-36,300
-20% -$3.55M 0.13% 177
2023
Q1 		$18.3M Buy
180,323
+3,523
+2% +$367K 0.19% 151
2022
Q4 		$21.1M Sell
176,800
-6,200
-3% -$726K 0.22% 118
2022
Q3 		$19.4M Buy
+183,000
New +$18.6M 0.22% 121
2021
Q2 		– Sell
-2,700
Closed -$263K – 1104
2021
Q1 		$263K Buy
+2,700
New +$283K ﹤0.01% 1023
2020
Q3 		– Sell
-14,700
Closed -$1.79M – 1144
2020
Q2 		$1.79M Buy
14,700
+8,900
+153% +$984K 0.02% 402
2020
Q1 		$502K Sell
5,800
-20,100
-78% -$1.97M 0.01% 793
2019
Q4 		$2.78M Buy
25,900
+8,900
+52% +$932K 0.03% 382
2019
Q3 		$1.53M Buy
17,000
+200
+1% +$18.7K 0.02% 517
2019
Q2 		$1.42M Buy
16,800
+7,900
+89% +$649K 0.02% 547
2019
Q1 		$784K Buy
8,900
+2,700
+44% +$226K 0.01% 752
2018
Q4 		$443K Hold
6,200
– – 0.01% 908
2018
Q3 		$762K Hold
6,200
– – 0.01% 795
2018
Q2 		$609K Buy
+6,200
New +$555K 0.01% 845

Other funds holding NBIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Virginia Retirement Systems's NBIX Position: Q2 2026 in Review

Virginia Retirement Systems increased its Neurocrine Biosciences (NBIX) stake by 41% in Q2 2026, buying an estimated $10.5M and bringing the position to 245,923 shares worth $41.4M. The position accounts for 0.25% of the portfolio, ranked #115.

Virginia Retirement Systems first reported a position in NBIX in Q2 2018 and has held it in 21 quarters since. The position peaked at $67.6M in Q3 2023. 777 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

  • Virginia Retirement Systems held 245,923 shares of Neurocrine Biosciences worth $41.4M as of Q2 2026.
  • Virginia Retirement Systems bought 70,900 Neurocrine Biosciences shares in Q2 2026, an estimated $10.5M.
  • Neurocrine Biosciences made up 0.25% of Virginia Retirement Systems's portfolio in Q2 2026, its #115 holding.
  • Virginia Retirement Systems first reported a position in Neurocrine Biosciences in Q2 2018 and has held it in 21 quarters since.
  • Virginia Retirement Systems's Neurocrine Biosciences position peaked at $67.6M in Q3 2023.
  • 777 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on Virginia Retirement Systems's 13F filing for Q2 2026, filed 25 Aug 2026.